• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Next Generation Sequencing (Genome/Exome sequencing/DNA sequencing) Global market - Forecast to 2020 - Product Image Special Offer Sale Banner

Next Generation Sequencing (Genome/Exome sequencing/DNA sequencing) Global market - Forecast to 2020

  • ID: 2924717
  • November 2014
  • Region: Global
  • 304 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
Special Offer Banner
UP TO
20%
OFF
Offer ends 31st Dec 2014

FEATURED COMPANIES

  • Beijing Genome Institute
  • Biomatters, Ltd.
  • Genomatix Software Gmbh
  • Illumina Inc.
  • Life Technologies Corp.
  • QIAGEN N.V
  • MORE

Next Generation Sequencing (NGS) enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes capable of producing hundreds of gigabases of data in a single sequencing run. NGS is one of the fastest growing segments in genomics, triggering several ground breaking discoveries in genomic science. NGS technologies will therefore have a striking impact on cancer management, treatments of rare diseases and future developments of genetic therapies. The global next generation sequencing market is mainly categorized into pre-sequencing, NGS platforms and services, NGS data analysis, and storage and management.

Next generation sequencing market is one of the fastest growing segments in the genomics market with an estimated CAGR of around 17.0% in the next five years. The major factors such as rapid adoption of this technology by researchers and its usability as a substitute of microarray technology in addition to its higher throughput, increased accuracy, and affordable costs are driving the next generation sequencing market growth. However, factors such as reducing capital expenditure from academic institutions and huge dependability on grants funding from the READ MORE >

FEATURED COMPANIES

  • Beijing Genome Institute
  • Biomatters, Ltd.
  • Genomatix Software Gmbh
  • Illumina Inc.
  • Life Technologies Corp.
  • QIAGEN N.V
  • MORE

1 Executive Summary

2 Introduction
2.1 Key Take Aways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Crackdown And Data Triangulation
2.5.3 Secondary Sources
2.5.4 Primary Sources
2.5.5 Key Data Points From Secondary Sources
2.5.6 Key Data Points From Primary Sources
2.5.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunities
3.3.1.1 Reduced Cost And High Speed
3.3.1.2 Increased Usage In Clinical Diagnosis
3.3.1.3 Switch To Ngs From Microarray Technology
3.3.1.4 New & Emerging Applications Of Ngs Technology
3.3.1.5 Growth Of Personalized Medicine And Biomarker Segments
3.3.1.6 Rising Demand For Ngs Discovery Technology
3.3.1.7 Increased Medical Spending
3.3.1.8 Rise In Incidence Of Chronic Disease
3.3.1.9 Emerging Technologies
3.3.2 Restraints And Threats
3.3.2.1 Complications In Ngs Data Storage
3.3.2.2 Standardization Of Ngs For Diagnostic Application
3.3.2.3 Grants And Funding For Ngs Infrastructure
3.3.2.4 Lack Of Skilled Labor
3.3.2.5 Huge Data Interpretation Of Ngs
3.3.2.6 Ethical And Legal Issues To Ngs
3.3.3 Burning Issues
3.3.3.1 Reduced Cost Leads To Complexity In Data Storage
3.4 Porter’S Five Force Analysis
3.4.1 Threat Of New Entrants
3.4.2 Threat Of Substitutes
3.4.3 Bargaining Power Of Suppliers
3.4.4 Bargaining Power Of Buyers
3.4.5 Competitive Rivalry
3.5 Regulatory Affairs
3.5.1 U.S.
3.5.2 Europe
3.5.3 China
3.6 Market Share Analysis By Major Players

4 Next Generation Sequencing Market, By Products
4.1 Introduction
4.2 Instruments And Consumbales
4.3 Services
4.4 Workflow Products

5 Next Generation Sequencing Market Value And Volume Analysis, By Technology
5.1 Introduction
5.1.1 Ngs Platform Installation Base
5.1.2 Ngs Market Revenue, By Technology
5.1.3 Ngs Sample Market Volume, By Technology
5.2 Targeted Resequencing
5.2.1 Targeted Resequencing Market Revenue, By Region
5.2.2 Targeted Resequencing Samples Market Volume, By Region
5.3 Whole Exome Sequencing
5.3.1 Whole Exome Sequencing Market Revenue, By Region
5.3.2 Whole Exome Sequencing Samples Market Volume, By Region
5.4 Rna Sequencing
5.4.1 Rna Sequencing Market Revenue, By Region
5.4.2 Rna Sequencing Samples Market Volume, By Region
5.5 Whole Genome Sequencing
5.5.1 Whole Genome Sequencing Market Revenue, By Region
5.5.2 Whole Genome Sequencing Samples Market Volume, By Region
5.6 Chip Sequencing
5.6.1 Chip Sequencing Market Revenue, By Region
5.6.2 Chip Sequencing Samples Market Volume, By Region
5.7 De Novo Sequencing
5.7.1 De Novo Sequencing Market Revenue, By Region
5.7.2 De Novo Sequencing Samples Market Volume, By Region
5.8 Methyl Sequencing
5.8.1 Methyl Sequencing Market Revenue, By Region
5.8.2 Methyl Sequencing Samples Market Volume, By Region

6 Next Generation Sequencing Market, By End Users/Laboratories
6.1 Introduction
6.1.1 Ngs Market Revenue By End-Users/ Laboratories
6.1.2 Ngs Samples Market Volume By End-Users/ Laboratories
6.1.3 Ngs Laboratories Volume Market By End- Users
6.1.4 Ngs Laboratories Volume Market By Lab Type
6.1.5 Ngs Laboratories Volume Market By Region
6.2 Academic Research
6.2.1 Academic Research Market Revenue By Region
6.2.2 Academic Research Samples Market Volume By Region
6.3 Hospitals And Clinics
6.3.1 Hospitals And Clinics Market Revenue By Region
6.3.2 Hospitals And Clinics Samples Market Volume By Region
6.4 Biotech/Pharmaceuticals
6.4.1 Biotech/Pharmaceuticals Market Revenue By Region
6.4.2 Biotech/Pharmaceuticals Samples Market Volume By Region
6.5 Other End Users
6.5.1 Other End-Users Market Revenue By Region
6.5.2 Other End-Users Samples Market Volume By Region

7 Next Generation Sequencing Market Value And Volume Analysis, By Application Area
7.1 Introduction
7.1.1 Ngs Market Revenue By Application Type
7.1.2 Ngs Samples Market Volume By Application Type
7.2 Overall Applications Market
7.2.1 Oncology
7.2.1.1 Ngs Oncology Market Revenue By Application Type
7.2.1.2 Ngs Oncology Market Revenue By Region
7.2.1.3 Ngs Oncology Samples Market Volume By Region
7.2.2 Genetic Screening
7.2.2.1 Ngs Genetic Screening Market Revenue By Application Type
7.2.2.2 Ngs Genetic Screening Market Revenue By Region
7.2.2.3 Ngs Genetic Screening Samples Market Volume By Region
7.2.3 Infectious Diseases
7.2.3.1 Ngs Infectious Diseases Market Revenue By Region
7.2.3.2 Ngs Infectious Samples Market Volume By Region
7.2.4 Drug And Biomarker Discovery
7.2.4.1 Ngs Drug And Biomarker Discovery Market Revenue By Region
7.2.4.2 Ngs Drug And Biomarker Discovery Samples Market Volume By Region
7.2.5 Molecular Epidemiology
7.2.5.1 Ngs Molecular Epidemiology Market Revenue By Region
7.2.5.2 Ngs Molecular Epidemiology Samples Market Volume By Region
7.2.6 Agriculture And Animal Research
7.2.6.1 Ngs Agriculture And Animal Research Market Revenue By Region
7.2.6.2 Ngs Agriculture And Animal Research Samples Market Volume By Region
7.2.7 Other Applications
7.2.7.1 Ngs Other Applications Market Revenue By Region
7.2.7.2 Ngs Other Applications Samples Market Volume By Region
7.3 Ngs Clinical And Non-Clinical Applications
7.3.1 Introduction
7.3.1.1 Ngs Market Revenue By Clinical And Non-Clinical Application
7.3.1.2 Ngs Samples Market Volume By Clinical And Non-Clinical Application
7.3.2 Clinical
7.3.2.1 Ngs Clinical Application Market Revenue, By Type
7.3.2.2 Ngs Clinical Application Market Revenue, By Region
7.3.2.3 Oncology
7.3.2.3.1 Ngs Clinical Oncology Market Revenue By Region
7.3.2.4 Genetic Screening
7.3.2.4.1 Ngs Clinical Genetic Screening Market Revenue By Region
7.3.2.5 Infectious Diseases
7.3.2.5.1 Ngs Clinical Infectious Diseases Market Revenue By Region
7.3.2.6 Other Clinical Applications
7.3.2.6.1 Ngs Other Clinical Applications Market Revenue By Region
7.3.3 Non-Clinical
7.3.3.1 Ngs Non-Clinical Application Market Revenue, By Type
7.3.3.2 Ngs Non-Clinical Application Market Revenue, By Region
7.3.3.3 Oncology
7.3.3.3.1 Ngs Non-Clinical Oncology Market Revenue By Region
7.3.3.4 Genetic Screening
7.3.3.4.1 Ngs Non-Clinical Genetic Screening Market Revenue By Region
7.3.3.5 Infectious Diseases
7.3.3.5.1 Ngs Non-Clinical Infectious Diseases Market Revenue By Region
7.3.3.6 Drug And Biomarker Discovery
7.3.3.6.1 Ngs Drug And Biomarker Discovery Market Revenue By Region
7.3.3.7 Molecular Epidemiology
7.3.3.7.1 Ngs Molecular Epidemiology Market Revenue By Region
7.3.3.8 Agriculture And Animal Research
7.3.3.8.1 Ngs Agriculture And Animal Research Market Revenue By Region
7.3.3.9 Other Non-Clinical Applications
7.3.3.9.1 Ngs Other Non-Clinical Applications Market Revenue By Region

8 Geographic Analysis
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia-Pacific
8.5 Rest Of The World

9 Company Developments
9.1 Introduction
9.2 Agreements, Partnership, Collaboration & Joint Ventures
9.3 New Product Launches
9.4 Approvals
9.5 Merges & Acquisitions
9.6 Other Developments

10 Major Player Profiles
10.1 Agilent Technologies, Inc.
10.1.1 Overview
10.1.2 Financials
10.1.3 Product Portfolio
10.1.4 Key Developments
10.1.5 Business Strategy
10.1.6 Swot Analysis
10.2 Bgi (Beijing Genomics Institute)
10.2.1 Overview
10.2.2 Financials
10.2.3 Product Portfolio
10.2.4 Key Developments
10.2.5 Business Strategy
10.2.6 Swot Analysis
10.3 Biomatters Ltd
10.3.1 Overview
10.3.2 Financials
10.3.3 Product Portfolio
10.3.4 Key Developments
10.3.5 Business Strategy
10.3.6 Swot Analysis
10.4 Genomatix Software Gmbh
10.4.1 Overview
10.4.2 Financials
10.4.3 Product Portfolio
10.4.4 Key Developments
10.4.5 Business Strategy
10.4.6 Swot Analysis
10.5 Illumina, Inc.
10.5.1 Overview
10.5.2 Financials
10.5.3 Product Portfolio
10.5.4 Key Developments
10.5.5 Business Strategy
10.5.6 Swot Analysis
10.6 Pacific Biosciences Of California Inc.
10.6.1 Overview
10.6.2 Financials
10.6.3 Product Portfolio
10.6.4 Key Developments
10.6.5 Business Strategy
10.6.6 Swot Analysis
10.7 Qiagen N.V.
10.7.1 Overview
10.7.2 Financials
10.7.3 Product Portfolio
10.7.4 Key Developments
10.7.5 Business Strategy
10.7.6 Swot Analysis
10.8 Hoffmann-La Roche Ltd.
10.8.1 Overview
10.8.2 Financials
10.8.3 Product Portfolio
10.8.4 Key Developments
10.8.5 Business Strategy
10.8.6 Swot Analysis
10.9 Strand Life Sciences Pvt. Ltd.
10.9.1 Overview
10.9.2 Financials
10.9.3 Product Portfolio
10.9.4 Key Developments
10.9.5 Business Strategy
10.9.6 Swot Analysis
10.10 Thermo Fisher Scientific Inc.
10.10.1 Overview
10.10.2 Financials
10.10.3 Product Portfolio
10.10.4 Key Developments
10.10.5 Business Strategy
10.10.6 Swot Analysis

List Of Tables

Table 1 Global Ngs Market Revenue, By Products, (2012-2020) ($Mn)
Table 2 Global Ngs Market Revenue, By Technology, (2012-2020) ($Mn)
Table 3 Global Ngs Market Revenue, By End-Users/Laboratories, (2012-2020) ($Mn)
Table 4 Global Ngs Market Revenue, By Application Type, (2012-2020) ($Mn)
Table 5 Global Ngs Market Revenue, By Region, (2012-2020) ($Mn)
Table 6 Emerging Companies
Table 7 Global Ngs Market Revenue, By Products, (2012-2020) ($Mn)
Table 8 Global Ngs Instruments & Consumables Market Revenue, By Region, (2012-2020) ($Mn)
Table 9 Global Ngs Services Market Revenue, By Region, (2012-2020) ($Mn)
Table 10 Global Ngs Workflow Products Market Revenue, By Region, (2012-2020) ($Mn)
Table 11 Global Ngs Market Revenue, By Technology, (2012-2020) ($Mn)
Table 12 Global Ngs Sample Market Volume, By Technology, (2012-2020) (No’S)
Table 13 Global Targeted Resequencing Market Revenue, By Region, (2012-2020) ($Mn)
Table 14 Global Targeted Resequencing Samples Market Volume, By Region, (2012-2020) (No’S)
Table 15 Global Whole Exome Sequencing Market Revenue, By Region, (2012-2020) ($Mn)
Table 16 Global Whole Exome Sequencing Samples Market Volume, By Region, (2012-2020) (No’S)
Table 17 Global Rna Sequencing Market Revenue, By Region, (2012-2020) ($Mn)
Table 18 Global Rna Sequencing Samples Market Volume, By Region, (2012-2020) (No’S)
Table 19 Global Whole Genome Sequencing Market Revenue, By Region, (2012-2020) ($Mn)
Table 20 Global Whole Genome Sequenicng Samples Market Volume, By Region, (2012-2020) (No’S)
Table 21 Global Chip Sequencing Market Revenue, By Region, (2012-2020) ($Mn)
Table 22 Global Chip Sequencing Samples Market Volume, By Region, (2012-2020) (No’S)
Table 23 Global De Novo Sequencing Market Revenue, By Region, (2012-2020) ($Mn)
Table 24 Global De Novo Sequencing Samples Market Volume, By Region, (2012-2020) (No’S)
Table 25 Global Methyl Sequencing Market Revenue, By Region, (2012-2020) ($Mn)
Table 26 Global Methyl Sequencing Samples Market Volume, By Region, (2012-2020) (No’S)
Table 27 Global Ngs Market Revenue, By End-Users/Laboratories, (2012-2020) ($Mn)
Table 28 Global Ngs Samples Market Volume, By End-Users/Laboratories, (2012-2020) (No’S)
Table 29 Global Ngs Laboratory Market Volume, By End-Users, (2012-2020) (No's)
Table 30 Global Ngs Laboratories Market Volume, By Type, (2012-2020) (No's)
Table 31 Global Ngs Laboratories Market Volume, By Region, (2012-2020) (No’S)
Table 32 Global Academic Research Market Ngs Revenue, By Region, (2012-2020) ($Mn)
Table 33 Global Academic Research Ngs Samples Market Volume, By Region, (2012-2020) (No’S)
Table 34 Global Hospitals And Clinics Ngs Market Revenue, By Region, (2012-2020) ($Mn)
Table 35 Global Hospitals And Clinics Ngs Samples Market Volume, By Region, (2012-2020)(No’S)
Table 36 Global Biotech/Pharmaceuticals Ngs Market Revenue, By Region,(2012-2020) ($Mn)
Table 37 Global Biotech/Pharmaceuticals Ngs Samples Market Volume, By Region, (2012-2020)(No’S)
Table 38 Global Other End Users Ngs Market Revenue, By Region, (2012-2020) ($Mn)
Table 39 Global Other End Users Ngs Samples Market Volume, By Region, (2012-2020)(No’S)
Table 40 Global Ngs Market Revenue, By Application Type, (2012-2020) ($Mn)
Table 41 Global Ngs Samples Market Volume, By Application Type, (2012-2020) (No’S)
Table 42 Global Ngs Market Revenue, By Oncology Application, (2012-2020) ($Mn)
Table 43 Global Ngs Oncology Market Revenue, By Region, (2012-2020) ($Mn)
Table 44 Global Ngs Oncology Samples Market Volume, By Region, (2012-2020) (No’S)
Table 45 Global Ngs Market Revenue, By Genetic Screening Application, (2012-2020) ($Mn)
Table 46 Global Ngs Genetic Screening Market Revenue, By Region, (2012-2020) ($Mn)
Table 47 Global Ngs Genetic Screening Samples Market Volume, By Region, (2012-2020) (No’S)
Table 48 Global Ngs Infectious Disease Market Revenue, By Region, (2012-2020) ($Mn)
Table 49 Global Ngs Infectious Diseases Samples Market Volume, By Region, (2012-2020) (No’S)
Table 50 Global Ngs Drug And Biomarker Discovery Market Revenue, By Region, (2012-2020) ($Mn)
Table 51 Global Ngs Drug And Biomarker Discovery Samples Market Volume, By Region, (2012-2020) (No’S)
Table 52 Global Ngs Molecular Epidemiology Market Revenue, By Region, (2012-2020) ($Mn)
Table 53 Global Ngs Molecular Epidemiology Samples Market Volume, By Region, (2012-2020) (No’S)
Table 54 Global Ngs Agriculture And Animal Research Market Revenue, By Region, (2012-2020) ($Mn)
Table 55 Global Ngs Agriculture And Animal Research Samples Market Volume, By Region, (2012-2020) (No’S)
Table 56 Global Ngs Other Applications Market Revenue, By Region, (2012-2020) ($Mn)
Table 57 Global Ngs Other Applications Samples Market Volume, By Region, (2012-2020) (No’S)
Table 58 Global Ngs Market Revenue, By Application, (2012-2020) ($Mn)
Table 59 Global Ngs Samples Market Volume By Application, (2012-2020) (No’S)
Table 60 Global Ngs Clinical Application Market Revenue, By Type (2012-2020) ($Mn)
Table 61 Global Ngs Clinical Application Market Revenue, By Region, (2012-2020) ($Mn)
Table 62 Global Ngs Clinical Oncology Application Market Revenue, By Region, (2012-2020) ($Mn)
Table 63 Global Ngs Clinical Genetic Engineering Application Market Revenue, By Region, (2012-2020) ($Mn)
Table 64 Global Ngs Clinical Infectious Diseases Application Market Revenue, By Region, (2012-2020) ($Mn)
Table 65 Global Ngs Other Clinical Application Market Revenue, By Region, (2012-2020) ($Mn)
Table 66 Global Ngs Non-Clinical Application Market Revenue, By Type (2012-2020) ($Mn)
Table 67 Global Ngs Non-Clinical Application Market Revenue, By Region, (2012-2020) ($Mn)
Table 68 Global Ngs Non-Clinical Oncology Application Market Revenue, By Region, (2012-2020) ($Mn)
Table 69 Global Ngs Non-Clinical Genetic Engineering Application Market Revenue, By Region, (2012-2020) ($Mn)
Table 70 Global Ngs Non-Clinical Infectious Diseases Application Market Revenue, By Region, (2012-2020) ($Mn)
Table 71 Global Ngs Non-Clinical Drug And Biomarker Discovery Application Market Revenue, By Region, (2012-2020) ($Mn)
Table 72 Global Ngs Non-Clinical Molecular Epidemiology Application Market Revenue, By Region, (2012-2020) ($Mn) 1
Table 73 Global Ngs Non-Clinical Agriculture And Animal Research Application
Market Revenue, By Region, (2012-2020) ($Mn)
Table 74 Global Ngs Other Non-Clinical Application Market Revenue, By Region, (2012-2020) ($Mn)
Table 75 Global Ngs Market Revenue, By Region, (2012-2020) ($Mn)
Table 76 North American Ngs Market Revenue, By Technology, (2012-2020) ($Mn)
Table 77 North American Ngs Samples Market Volume, By Technology, (2012-2020) (No’S)
Table 78 North American Ngs Market Revenue, By End-Users/Laboratories, (2012-2020) ($Mn)
Table 79 North American Ngs Samples Market Volume, By End-Users/Laboratories, (2012-2020) (No’S)
Table 80 North American Ngs Market Revenue, By Application (2012-2020) ($Mn)
Table 81 North American Ngs Market Revenue, By Application Type (2012-2020) ($Mn)
Table 82 European Ngs Market Revenue, By Technology, (2012-2020) ($Mn)
Table 83 European Ngs Samples Market Volume, By Technology, (2012-2020) (No’S)
Table 84 European Ngs Market Revenue, By End-Users/Laboratories, (2012-2020) ($Mn)
Table 85 European Ngs Samples Market Volume, By End-Users/Laboratories, (2012-2020) (No’S)
Table 86 European Ngs Market Revenue, By Application, (2012-2020) ($Mn)
Table 87 European Ngs Market Revenue, By Application Type, (2012-2020) ($Mn)
Table 88 Asia-Pacific Ngs Market Revenue, By Technology, (2012-2020) ($Mn)
Table 89 Asia-Pacific Ngs Samples Market Volume, By Technology, (2012-2020) (No’S)
Table 90 Asia-Pacific Ngs Market Revenue, By End-Users/Laboratories, (2012-2020) ($Mn)
Table 91 Asia-Pacific Ngs Samples Market Volume, By End-Users/Laboratories, (2012-2020) (No’S)
Table 92 Asia-Pacific Ngs Market Revenue, By Application, (2012-2020) ($Mn)
Table 93 Asia-Pacific Ngs Market Revenue, By Application Type, (2012-2020) ($Mn)
Table 94 Rest Of The World Ngs Market Revenue, By Technology, (2012-2020) ($Mn)
Table 95 Rest Of The World Ngs Samples Market Volume, By Technology, (2012-2020) (No’S)
Table 96 Rest Of The World Ngs Market Revenue, By End-Users/Laboratories, (2012-2020) ($Mn)
Table 97 Rest Of The World Ngs Samples Market Volume, By End-Users/Laboratories, (2012-2020) (No’S)
Table 98 Rest Of The World Ngs Market Revenue, By Application, (2012-2020) ($Mn)
Table 99 Rest Of The World Ngs Market Revenue, By Application Type, (2012-2020) ($Mn)
Table 100 Agreements, Partnership, Collaboration & Joint Ventures (2011-2014)
Table 101 New Product Launches (2011-2014)
Table 102 Approvals (2011-2014)
Table 103 Merges & Acquisitions (2011-2014)
Table 104 Other Developments (2011-2014)
Table 105 Agilent Technologies, Inc.: Total Revenue And R&D Expenses (2011-2013) ($Mn)
Table 106 Agilent Technologies, Inc.: Total Revenue, By Segments, (2011-2013) ($Mn)
Table 107 Agilent Technologies, Inc.: Total Revenue, By Geography, (2011-2013) ($Mn)
Table 108 Illumina Inc: Total Revenue And R&D Expenses (2011-2013) ($Mn)
Table 109 Illumina Inc: Total Revenue, By Geography, (2011-2013) ($Mn)
Table 110 Pacific Biosciences: Total Revenue And R&D Expenses (2011-2013) ($Mn)
Table 111 Pacific Biosciences: Total Revenue, By Segment, (2011-2013) ($Mn)
Table 112 Pacific Biosciences: Total Revenue, By Geography, (2011-2013) ($Mn)
Table 113 Qiagen’S: Total Revenue And R&D Expenses, (2011-2013) ($Mn)
Table 114 Qiagen’S: Total Revenue, By Segments, (2011-2013) ($N)
Table 115 Qiagen’S: Total Revenue, By Geography, (2011-2013) ($Mn)
Table 116 Roche’S: Total Revenue And Operating R&D Expenses, (2011-2013) ($Bn)
Table 117 Roche’S: Total Revenue, By Segments, (2011-2013) ($Bn)
Table 118 Roche’S: Diagnostics Revenue, By Segments, (2011-2013) ($Bn)
Table 119 Roche’S: Total Revenue, By Geography (2011-2013) ($Bn)
Table 120 Thermo Fisher Scientific Inc.: Total Revenue And R&D Expenses (2011-2013) ($Bn)
Table 121 Thermo Fisher Scientific Inc.: Total Revenue, By Segments (2011-2013) ($Bn)
Table 122 Thermo Fisher Scientific Inc.: Total Revenue, By Geography (2011-2013) ($Bn)

List Of Figures:

Figure 1 Global Ngs Market Scenario, By Region (2012-2020)
Figure 2 Research Methodology: Next Generation Sequencing Market
Figure 3 Ngs Market: Top-Down And Bottom-Up Approach
Figure 4 Ngs Market: Forecasting Model
Figure 5 Ngs Market: Market Crachdown And Data Triangulation
Figure 6 Ngs Market: Market Segmentation
Figure 7 Market Dynamics
Figure 8 Ngs Market: Porter’S Analysis
Figure 9 Global Ngs Market Share, By Key Player’S (2013)
Figure 10 Global Ngs Market Share, By Products (2012 - 2020)
Figure 11 Ngs Platform Installation Base (2013)
Figure 12 Ngs Technology Market Scenario, (2013 - 2020)
Figure 13 Global Ngs Laboratories Volume Market, By End-Users (2012 - 2020)
Figure 14 Global Ngs Market Share, By Application (2013 V’S 2020)
Figure 15 Global Ngs Application Market Share 2020 (Non-Clinical V’S Clinical)
Figure 16 Global Ngs Market Scenario, By Region (2012 - 2020)
Figure 17 Key Grwoth Strategies, (2012 - 2014)
Figure 18 Swot Analysis: Agiltent Technologies Inc
Figure 19 Swot Analysis: Bgi (Beijing Genomics Institute)
Figure 20 Swot Analysis: Biomatters Ltd
Figure 21 Swot Analysis: Genomatix Software Gmbh
Figure 22 Swot Analysis: Illumina, Inc.
Figure 23 Swot: Pacific Biosciences Of California, Inc.
Figure 24 Swot: Qiagen.N.V
Figure 25 Swot: Hoffmann-La Roche Ltd
Figure 26 Swot: Strand Life Sciences Pvt. Ltd.
Figure 27 Swot: Thermo Fishers Scientific, Inc.

- Agilent Technologies, Inc.
- Beijing Genome Institute
- Biomatters, Ltd.
- Genomatix Software Gmbh
- Illumina Inc.
- Life Technologies Corp.
- Pacific Biosciences of California Inc.
- QIAGEN N.V
- Roche Holding Ltd.
- Strand Life Sciences Pvt. Ltd.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos